4.7 Article

Proteomic and Biological Analysis of the Effects of Metformin Senomorphics on the Mesenchymal Stromal Cells

Related references

Note: Only part of the references are listed.
Review Endocrinology & Metabolism

Cellular and Molecular Mechanisms of Metformin Action

Traci E. LaMoia et al.

Summary: Metformin is a commonly used first-line therapy for type 2 diabetes, mainly acting through inhibition of hepatic gluconeogenesis to lower blood glucose levels. Despite controversy over its mechanism of action, recent studies have supported a redox-dependent mechanism.

ENDOCRINE REVIEWS (2021)

Article Cell Biology

Metformin inhibits chronic kidney disease-induced DNA damage and senescence of mesenchymal stem cells

Hyoungnae Kim et al.

Summary: Research has shown that MSCs from patients with CKD exhibit reduced proliferation, accelerated senescence, and increased DNA damage compared to healthy MSCs, but these changes were significantly reduced after metformin treatment. Metformin enhances the paracrine action of CKD MSCs, leading to lower expression of inflammatory and fibrotic markers in kidney cells co-cultured with metformin-treated MSCs. Furthermore, metformin-treated CKD MSCs effectively reduce inflammation and fibrosis in diseased kidneys, suggesting a therapeutic benefit in targeting accelerated senescence of CKD MSCs.

AGING CELL (2021)

Review Pharmacology & Pharmacy

Senescence and senotherapeutics: a new field in cancer therapy

Vassilios Myrianthopoulos et al.

PHARMACOLOGY & THERAPEUTICS (2019)

Review Biochemistry & Molecular Biology

Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases

Toshitaka Nakamura et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2019)

Article Multidisciplinary Sciences

HSP90 inhibitors stimulate DNAJB4 protein expression through a mechanism involving N6-methyladenosine

Weili Miao et al.

NATURE COMMUNICATIONS (2019)

Article Biochemistry & Molecular Biology

The PRIDE database and related tools and resources in 2019: improving support for quantification data

Yasset Perez-Riverol et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Biotechnology & Applied Microbiology

Senotherapeutics for healthy ageing

Laura J. Niedernhofer et al.

NATURE REVIEWS DRUG DISCOVERY (2018)

Article Medicine, Research & Experimental

Prolonged incubation with Metformin decreased angiogenic potential in human bone marrow mesenchymal stem cells

Soheila Montazersaheb et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Article Pharmacology & Pharmacy

PXR: More Than Just a Master Xenobiotic Receptor

Peter O. Oladimeji et al.

MOLECULAR PHARMACOLOGY (2017)

Article Medicine, General & Internal

Metformin Enhances Osteogenesis and Suppresses Adipogenesis of Human Chorionic Villous Mesenchymal Stem Cells

Qiaoli Gu et al.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2017)

Review Medicine, General & Internal

Telomeres and Cell Senescence - Size Matters Not

Stella Victorelli et al.

EBIOMEDICINE (2017)

Review Endocrinology & Metabolism

Metformin and ageing: improving ageing outcomes beyond glycaemic control

Willy Marcos Valencia et al.

DIABETOLOGIA (2017)

Review Cell Biology

ROS, Cell Senescence, and Novel Molecular Mechanisms in Aging and Age-Related Diseases

Pierpaola Davalli et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)

Review Multidisciplinary Sciences

The role of senescent cells in ageing

Jan M. van Deursen

NATURE (2014)

Article Multidisciplinary Sciences

Dopamine Regulates Mobilization of Mesenchymal Stem Cells during Wound Angiogenesis

Saurav Shome et al.

PLOS ONE (2012)

Article Pharmacology & Pharmacy

Metformin regulates osteoblast and adipocyte differentiation of rat mesenchymal stem cells

Ying Gao et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2008)

Review Cell Biology

Cellular senescence: when bad things happen to good cells

Judith Campisi et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)